Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines

Por Manzini, Giulia, Henne-Bruns, Doris, Porzsolt, Franz, Kremer, Michael
Publicado no BMJ Open Gastroenterol (2017)

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)

Por Orditura, Michele, Gravina, Adriano, Riccardi, Ferdinando, Diana, Anna, Mocerino, Carmela, Leopaldi, Luigi, Fabozzi, Alessio, Giordano, Guido, Nettuno, Raffaele, Incoronato, Pasquale, Barzelloni, Maria Luisa, Caputo, Roberta, Pisano, Agata, Grimaldi, Giuseppe, Genua, Geppino, Montesarchio, Vincenzo, Barbato, Enrico, Iodice, Giovanni, Lieto, Eva, Procaccini, Eugenio, Mabilia, Roberto, Febbraro, Antonio, Laurentiis, Michelino De, Ciardiello, Fortunato
Publicado no ESMO Open (2017)

Continuing EGFR-TKI beyond radiological progression in patients with advanced or recurrent, EGFR mutation-positive non-small-cell lung cancer: an observational study

Por Goto, Yasushi, Tanai, Chiharu, Yoh, Kiyotaka, Hosomi, Yukio, Sakai, Hiroshi, Kato, Terufumi, Kaburagi, Takayuki, Nishio, Makoto, Kim, Young Hak, Inoue, Akira, Hasegawa, Yoshinori, Isobe, Hiroshi, Tomizawa, Yoshio, Mori, Yoshiaki, Minato, Koichi, Yamada, Kazuhiko, Ohashi, Yasuo, Kunitoh, Hideo
Publicado no ESMO Open (2017)

Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

Por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

Por Keith, Bruce D
Publicado em 2008

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled tria...

Por van der Vorst, Maurice J. D. L, Neefjes, Elisabeth C. W., Konings, Inge R. H. M., Verheul, Henk M. W.
Publicado no Support Care Cancer (2015)

Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials

Por Huang, Jun, Zhao, Yongzhao, Xu, Yong, Zhu, Yanjie, Huang, Jiale, Liu, Yanna, Zhao, Liying, Li, Zhijia, Liu, Hao, Wang, Qi-long, Qi, Xiaolong
Publicado no Oncotarget (2016)

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

Por Márquez-Rodas, Iván, Pollán, Marina, Escudero, María José, Ruiz, Amparo, Martín, Miguel, Santaballa, Ana, Martínez del Prado, Purificación, Batista, Norberto, Andrés, Raquel, Antón, Antonio, Llombart, Antonio, Fernandez Aramburu, Antonio, Adrover, Encarnación, González, Sonia, Seguí, Miguel Angel, Calvo, Lourdes, Lizón, José, Rodríguez Lescure, Álvaro, Ramón y Cajal, Teresa, Llort, Gemma, Jara, Carlos, Carrasco, Eva, López-Tarruella, Sara
Publicado no PLoS One (2017)

Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors

Por Igarashi, Tomoyuki, Teramoto, Koji, Ishida, Mitsuaki, Hanaoka, Jun, Daigo, Yataro
Publicado no ESMO Open (2016)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

Por Liede, Alexander, Hallett, David C, Hope, Kirsty, Graham, Alex, Arellano, Jorge, Shahinian, Vahakn B
Publicado no ESMO Open (2016)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

Por Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F
Publicado no ESMO Open (2016)

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

Por Bonneterre, Jacques, Bosq, Jacques, Jamme, Philippe, Valent, Alexander, Gilles, Erard M, Zukiwski, Alexander A, Fuqua, Suzanne A W, Lange, Carol A, O'Shaughnessy, Joyce
Publicado no ESMO Open (2016)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers

Por Berghoff, Anna S, Schur, Sophie, Füreder, Lisa M, Gatterbauer, Brigitte, Dieckmann, Karin, Widhalm, Georg, Hainfellner, Johannes, Zielinski, Christoph C, Birner, Peter, Bartsch, Rupert, Preusser, Matthias
Publicado no ESMO Open (2016)

Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

Por Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Publicado no ESMO Open (2016)

Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use program...

Por Sforza, Vincenzo, Martinelli, Erika, Cardone, Claudia, Martini, Giulia, Napolitano, Stefania, Vitiello, Pietro Paolo, Vitale, Pasquale, Zanaletti, Nicoletta, Reginelli, Alfonso, Bisceglie, Maurizio Di, Latiano, Tiziana Pia, Bochicchio, Anna Maria, Cecere, Fabiana, Selvaggi, Francesco, Ciardiello, Fortunato, Troiani, Teresa
Publicado no ESMO Open (2017)

CBDCA + Pemetrexed + Bevacizumab and Its Maintenance Chemotherapy in a Case of Solitary Breast Metastasis from a Lung Adenocarcinoma Resistant to Gefitinib

Por Sato, Kazuhide, Takeyama, Yoshihiro, Yoshihara, Motoi, Kato, Toshio, Hashimoto, Hiroyuki, Fukui, Yasutaka, Gonda, Hideo, Suzuki, Ryujiro
Publicado em 2012

PCR-Based Assays versus Direct Sequencing for Evaluating the Effect of KRAS Status on Anti-EGFR Treatment Response in Colorectal Cancer Patients: A Systematic Review and Meta-Analy...

Por Shan, Lianfeng, Li, Ming, Ma, Jianzhong, Zhang, Huidan
Publicado em 2014

Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies

Por Heng, Daniel Y., Signorovitch, James, Swallow, Elyse, Li, Nanxin, Zhong, Yichen, Qin, Paige, Zhuo, Daisy Y., Wang, Xufang, Park, Jinhee, Stergiopoulos, Sotirios, Kollmannsberger, Christian
Publicado no PLoS One (2014)

Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Por Hu, Xingsheng, Pu, Ke, Feng, Xuqin, Wen, Shimin, Fu, Xi, Guo, Cuihua, He, Wenwu
Publicado no PLoS One (2016)

NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer

Por Das, Kakoli, Chan, Xiu Bin, Epstein, David, Teh, Bin Tean, Kim, Kyoung-Mee, Kim, Seung Tae, Park, Se Hoon, Kang, Won Ki, Rozen, Steve, Lee, Jeeyun, Tan, Patrick
Publicado no ESMO Open (2016)